ADVFN US – Market Content Editor
-
Bunge shares slip after short seller calls for accounting probe
Shares of Bunge Global SA (NYSE:BG) declined more than 2% in premarket trading Wednesday after short-selling firm Spruce Point Management released a report urging an independent investigation into the company’s accounting practices and financial disclosures. Spruce Point published what it described as a forensic analysis of the agribusiness group, arguing that the S&P 500 constituent…
-
Sarepta shares jump after early clinical data from siRNA programs
Shares of Sarepta Therapeutics (NASDAQ:SRPT) climbed about 14% after the company released preliminary clinical results from its siRNA-based pipeline targeting facio scapulo humeral muscular dystrophy type 1 (FSHD1) and myotonic dystrophy type 1 (DM1). The Cambridge, Massachusetts-based biotechnology company reported early findings from Phase 1/2 ascending-dose studies evaluating SRP-1001 for FSHD1 and SRP-1003 for DM1.…
-
Dell unveils redesigned commercial PC portfolio with built-in AI features
Dell Technologies (NYSE:DELL) has introduced a revamped lineup of commercial computing products, including Dell Pro notebooks, Dell Pro Precision workstations, desktops, monitors, and peripherals, the company said in a statement. The new Dell Pro notebook family features systems powered by Intel Core Ultra Series 3 processors and AMD Ryzen AI 400 chips, designed to support…
-
Freshpet shares edge higher as analysts downplay competitive concerns
Shares of Freshpet (NASDAQ:FRPT) rose modestly in premarket trading Monday, gaining about 63 basis points, after analysts at DA Davidson reiterated a Buy rating on the stock and downplayed concerns about new competition in the fresh pet food market. The stock had recently come under pressure following reports that The Farmer’s Dog plans to launch…
-
Beyond Meat delays 2025 results filing to March 31 amid accounting review
Beyond Meat Inc. (NASDAQ:BYND) said it will delay the release of its fourth-quarter and full-year 2025 financial results until March 31, 2026, as the company works to complete its financial closing process and address weaknesses in its internal accounting controls. The plant-based food producer disclosed a material weakness in its internal control over financial reporting…
-
Intel shares rise after report of planned CPU price increases
Shares of Intel Corporation (NASDAQ:INTC) climbed about 4% on Wednesday, while Advanced Micro Devices (NASDAQ:AMD) advanced roughly 2.5%, following a report that both companies have notified customers of upcoming price increases for their central processing units. According to Nikkei Asia, Intel and AMD have informed clients that they intend to raise prices across their entire…
-
Honeywell, Lockheed Martin shares edge higher following new defense agreements
Shares of Honeywell (NYSE:HON) rose about 1.3% to nearly $225 in premarket trading on Wednesday, while Lockheed Martin (NYSE:LMT) gained roughly 0.4% to around $613. Honeywell Aerospace announced that it has entered into a supplier framework agreement with the U.S. Department of War, supported by a multi-year $500 million investment aimed at expanding defense manufacturing…
-
Real Messenger signs preliminary agreement to explore tech rollout with U.S. brokerage
Real Messenger Corporation (NASDAQ:RMSG) said it has entered into a non-binding memorandum of understanding (MOU) with a publicly traded U.S. real estate brokerage to explore the potential deployment of its integrated technology platform across the brokerage’s network of agents. Under the preliminary agreement, the two companies will evaluate the use of Real Messenger’s platform across…
-
Quoin advances QRX003 development after positive FDA meeting on Netherton syndrome
Quoin Pharmaceuticals (NASDAQ:QNRX) said it received encouraging regulatory feedback from the U.S. Food and Drug Administration (FDA) following a Type C meeting held on March 25, 2026 regarding the development of QRX003, its investigational treatment for Netherton syndrome, a rare genetic skin disorder. According to the company, the FDA indicated that a single Phase 3…
-
Enlivex shares jump after earnings as treasury gains boost results
Shares of Enlivex Therapeutics Ltd (NASDAQ:ENLV) climbed nearly 16% after the company released its fourth-quarter 2025 results, supported by strong gains tied to its treasury holdings. The stock recently traded around $1.30, bringing its year-to-date return to roughly 56%. The biotechnology company said its financial performance was significantly strengthened by the appreciation of RAIN tokens,…